Affiliation:
1. The First Clinical Medical College of Guangzhou University of Traditional Chinese Medicine
2. the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
3. National Clinical Research Center for Cancer
4. the First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Abstract
Abstract
Objective: The aim of the study was to identify the immune-related genes (IRGs) associated with non-small cell lung cancer (NSCLC) metastasis, and establish a risk score prediction model.
Methods: Gene expression information and clinical data of NSCLC patients were downloaded from The Cancer Genome Atlas (TCGA) database. Differentially expressed genes (DEGs) were screened based on tumor group and normal group. DEGs were intersected with IRGs from the ImmPort database to obtain differentially expressed IRGs (DEIRGs). Weighted gene coexpression network analysis (WGCNA) was applied to determine the hub DEIRGs (HubDEIRGs) related to immune scores. Risk score was calculated based on the significant HubDEIRGs through logistic regression analyses. Logistic regression analysis was performed to analyze the influencing factors for metastasis with age, gender, T stage and risk score as covariates. A metastasis risk nomogram was constructed. The correlation between risk score and immune cells infiltration was examined.
Results: A total of 477 HubDEIRGs were identified. PDK1, PROC, IL11, SH2D1B, S100A5, AGT, WFDC2, CRHR2 and EREG were metastasis-associated immune genes. Age, T stage and risk score served as independent risk factors for metastasis. The areas under the curve (AUC) of the nomogram were 0.714 and 0.643 in the training and validation sets. The calibration curve was close to the ideal diagonal line. The high-risk group had a greater degree of immune infiltration than the low-risk group.
Conclusion: The risk scoring model for predicting the risk of metastasis in NSCLC patients based on 9 immune genes in this study had importantly potential clinical application value.
Publisher
Research Square Platform LLC
Reference23 articles.
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. ;71(3):209 – 49
2. Construction of an immune-related gene signature for prediction of prognosis in patients with cervical cancer;Mei J;Int Immunopharmacol,2020
3. Immune-related gene index predicts metastasis for prostate cancer patients undergoing radical radiotherapy;Feng D;Experimental Hematol Oncol,2023
4. Developing an immune-related gene prognostic index associated with progression and providing new insights into the tumor immune microenvironment of prostate cancer;Feng D;Immunology,2022
5. Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma;Liang Z;Front Immunol,2022